Invasive Fungal Infections Completed Phase 3 Trials for Posaconazole (DB01263)
Also known as: Invasive Fungal Infection / Invasive Mycosis / Invasive Infection, Fungal / Infection, Invasive Fungal / Invasive Fungal Disease / Fungal Invasive Disease / Invasive fungal infection (disorder) / Systemic fungal infection NOS / Disseminated mycosis / Systemic mycosis / Systemic mycosis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030131 (Invasive Fungal Infections) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00750737 | Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) | Treatment |